InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: petemantx post# 349364

Saturday, 02/27/2021 9:55:47 AM

Saturday, February 27, 2021 9:55:47 AM

Post# of 403741
I absolutely agree 100%. Leo, please continue to keep us in the dark to eliminate the share price manipulation and let Brilacidin run its course.

Go Leo & IPIX!

Keeping stockholders a bit uninformed vs possibly giving vital data to those that want to see IPIX decimated.

I know which side I favor.

IMO Leo has done his job giving investors all they need to know regarding the science of Brilacidin (peer review article), the results of the RBLs, and that B was Fast Tracked and approved for a P2 human trial. It is my opinion that is about all stockholders NEED to know, thought they may WANT to know far more.

If IPIX was a BP, what kind of news would one have expected to be given above what IPIX investors were told? I don't think much more, if even as much.

Also, I speak to a number of heavily invested players and they seem pretty happy with how things are progressing and PRs being issued. They don't complain about being given fluff PRs, ambiguous PRs, late PRs, etc they accept what is given and believe mgt has a reason to only put out what they do. As such, I feel complaints about the PRs are pretty much pure FUD.

I would love to be a fly on the IPIX mgt wall, but that is not the case. I don't really see what Leo has held back that has made investors buy/sell their shares and incur major losses. As to traders, I don't worry about them as they have their charts and other games to make their decisions.


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

Brilacidin in Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating COVID-19.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News